Search Results 331-340 of 25469 for actinic keratosis clinical trials
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor ...
Clinical Trials · Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia · More about research at Mayo Clinic · Mayo Clinic ...
The purpose of this study is to assess the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD)/recommended ...
The following tumor types are included in this study: Non-Small Cell Lung Cancer (NSCLC), gastric cancer, hepatocellular carcinoma, renal cell carcinoma, ...
The primary goal of this study is to establish a database of underrepresented populations who consented to be contacted for biomedical research including ...
About this study. The purpose of this study is to evaluate and compare 2 doses of AGTC-501 to an untreated control group. A single subretinal injection of ...
Rochester, Minn. This is a study to generate feasibilty data regarding the collection of health and psychosocial outcomes after acquired spinal cord injury (SCI).
This research study is being done to help characterize cardiovascular disease and improve diagnostic tests. OBJECTIVES. To understand the pathogenesis, ...
Mayo Clinic principal investigator. Eli Muchtar, M.D.. Contact information: Cancer Center Clinical Trials Referral Office. 855-776-0015. Open for enrollment ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.